• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Pregnancy and Postpartum Course
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » addiction

Articles Tagged with ''addiction''

Few Medications Effective for Cannabis Use Disorder

August 1, 2013
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
David A. Frenz, MD
While many people think marijuana is harmless, some people do become addicted to it. Roughly one million people receive substance abuse treatment for cannabis each year and the majority resume using marijuana following program discharge.
Read More

Cannabis Myths and Facts

August 1, 2013
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Separate the facts about cannabis use from the myths in an interview with Itai Danovitch, MD, director of Addiction Psychiatry Clinic Services at Cedars-Sinai Medical Center.
Read More

Lead Us Not Into Temptation

August 1, 2013
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Editor-in-Chief, David A. Frenz, MD
Smoking remains a scourge despite almost universal acknowledgement of its harms. This raises a puzzling question: If smoking is so bad for you, why do people continue to smoke?
Read More

New Drug Approved by FDA for Opioid Dependence

August 1, 2013
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
The FDA approved the use of Zubsolv on July 3. The medication contains buprenorphine and naloxone and is manufactured by Swedish drug maker Orexo AB. It comes in a once-daily tablet that dissolves under the tongue.
Read More

FDA Rejects Implant Option

August 1, 2013
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
The FDA rejected a new medication to treat opioid addiction that would have been implanted under the skin. The implant, Probuphine, is a long-acting version of buprenophine that is implanted under the skin of the upper arm in a procedure that can be done in a physician’s office in about 10–15 minutes.
Read More

Self-Medication of Mood Symptoms with Alcohol is a Risk Factor for Alcohol Dependence

July 1, 2013
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Patients often report alcohol use as a way to “self-medicate” mood symptoms. A new study demonstrates that this self-medication may serve as a precursor to the development or persistence of alcohol dependence, as defined by the DSM-IV.
Read More
Previous 1 2 … 15 16 17 18 19 20 21 22 23 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • PB5e_3DCover.png

    Psychiatry Practice Boosters, Fifth Edition (2026)

    This fifth edition teaches you the key points of 66 of the most clinically relevant studies in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2694929461.jpg
    Child Psychiatry

    ADHD in Young Adults: Assessment, Daily Functioning, and Support That Fits

    Working with young adults who are navigating ADHD is rarely straightforward. They’re often dealing with more than just distractibility or missed deadlines. There’s anxiety,...

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.